register

News & Trends - MedTech & Diagnostics

Urgent overhaul needed: Public hospitals at a level of deterioration not seen in 15 years

Health Industry Hub | May 1, 2023 |

MedTech & Diagnostics News: The Australian Medical Association (AMA) has called for an urgent overhaul of the National Health Reform Agreement (NHRA) in order to address the declining public hospital performance impacting patient care.

The AMA is urging all health ministers to work together to address the growing backlog of elective surgeries and the hidden waiting list of patients waiting years to see a specialist.

The demographics of Australia are shifting and the demand for public hospital services is increasing dramatically. Professor Robson reported that only 58% of patients triaged as urgent were seen within 30 minutes and one in three patients staying longer than four hours in EDs due to lack of beds available to admit them.

In the last 30 years, the number of public hospital beds available for people aged over 65 has dropped significantly, from 32.5 beds per 1,000 people to only 14.7.

“We’ve also seen wait times for essential surgeries blow out in the last financial year. It’s wrong to think of these as elective surgeries, they are essential and only 63% of patients referred for semi-urgent planned surgery are being treated within the recommended days. That’s more than one in three patients waiting longer than the clinically indicated time for essential surgeries, often in terrible pain and unable to work.

“Meanwhile, we also have a hidden waiting list with people sometimes waiting years to get in to see a specialist so they can get on to the official waiting list. We estimate that about 100,000 fewer people were added to the essential surgery list in 2021–22 as a result of these delays which shows the hidden waiting list is continuing to grow,” AMA’s President, Professor Steve Robson said.

Most of what was discussed at the National Cabinet meeting on Friday was relating to primary care reform. However, as people with multiple chronic health conditions are much more likely to go through emergency departments and require hospital care, the $2.2 billion package is aimed at making it easier for those patients to access primary care, out-of-hours care to keep them out of hospital, or care that allows them to leave hospitals earlier because care is available in the community.

Professor Robson emphasised that the current way of funding public hospitals is inadequate, and the current review of the NHRA is a chance to act.

“The funding arrangements as they stand are failing Australians and the Premiers and Chief Ministers understand that. We need to look at embedding long term reform in the way hospitals are funded and run that incentivises quality, that incentivises keeping people out of hospital,” said Professor Robson.

The AMA has proposed a new national hospital funding agreement that splits the funding 50/50 and provides hospitals with the resources they need to meet community demand. The AMA urges health ministers to consider this plan and take rapid action to address the hospital logjam.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Medtech, academia and government unite: Breaking down silos to deliver the power and promise of digital health to patients

Health Industry Hub | December 11, 2023 |

MedTech & Diagnostics News: In an interview with Health Industry Hub, Annette Schmiede, CEO of Digital Health Cooperative Research Centre […]

More


News & Trends - MedTech & Diagnostics

Two-decade evolution of robotic surgery in Australia's medical landscape

Two-decade evolution of robotic surgery in Australia’s medical landscape

Health Industry Hub | December 11, 2023 |

MedTech & Diagnostics News: In the past two decades, what was once deemed impossible in surgery has now become a […]

More


News & Trends - Pharmaceuticals

World-first in IVF: Merging AI and genomics to optimise treatment response

World-first in IVF: Merging AI and genomics to optimise treatment response for Australians

Health Industry Hub | December 11, 2023 |

Pharma News: A world-first Australian IVF study exploring genome sequencing has garnered enthusiastic reception from its collaborative research partners. Securing […]

More


News & Trends - Pharmaceuticals

PBS listing marks first oral therapy for childhood arthritis

PBS listing marks first oral therapy for childhood arthritis

Health Industry Hub | December 11, 2023 |

Pharma News: The first oral Janus kinase (JAK) inhibitor, Pfizer’s Xeljanz (tofacitinib), has been listed on the Pharmaceutical Benefits Scheme […]

More


This content is copyright protected. Please subscribe to gain access.